We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring

By LabMedica International staff writers
Posted on 28 Jul 2015
Print article
At AACC 2015 (July 26-30; Atlanta, GA, USA) research teams presented results of successful testing of two new potential methods for diagnosing and monitoring diabetes in its standard or gestational forms. The findings may lead to easier, timelier, and more affordable ways of identifying and treating this chronic disease.

One test study, by a research team led by Prof. Sridevi Devaraj, PhD, of Texas Children’s Hospital and Baylor College of Medicine (Houston, TX, USA), was to determine if a blood biomarker could be identified for gestational diabetes (GD), which occurs only during pregnancy and poses serious health risks for both mother and baby.

Today’s test for standard diabetes, which measures levels of the biomarker glycated hemoglobin (HbA1c), has limited usefulness for GD. The HbA1c test measures patient average glucose blood levels over a period of 3 months, and cannot be used to determine a patient’s blood glucose values on a daily, or even weekly, basis. This makes it challenging to closely track glucose levels during relatively few weeks of pregnancy, especially as GD is not diagnosed until the 3rd trimester.

Using stored blood samples collected from 124 pregnant women, Prof. Devaraj and her colleagues measured the levels of 3 types of proteins. They found that the levels of one—1,5Anhydroglucitol (1,5AG)—were significantly different in the women diagnosed with GD. The researchers were also able to establish a specific cutoff level at which the concentration of 1,5AG became a reliable predictor of which women had diabetes. One of the main potential advantages of 1,5AG as a biomarker for GD is its short “halflife” of 2 weeks, compared to HbA1c’s of 3 months.

“Our findings are very preliminary and need to be confirmed in larger groups of women,” said Prof. Devaraj, “but, if confirmed, they suggest a possible new and more immediate approach for diagnosing and monitoring diabetes during pregnancy.”

For the second test study, a research team led by Joris R. Delanghe, MD, PhD, Ghent University (Ghent, Belgium), investigated the novel view of whether fingernail clippings could be used instead of blood to diagnose and monitor diabetes. They collected nail clippings from 25 people with and 25 without diabetes. After the clippings were ground into powder, a relatively inexpensive spectrometer was used to measure the amount of nail protein that had undergone glycation (bonding with sugar molecules).

“We found a striking difference in the measurements between the control group and the patients with diabetes,” said Prof. Delanghe, “This finding suggests that nail clippings may serve as a reliable and noninvasive diagnostic tool,” with potential to make diagnosing diabetes much simpler and less expensive. Nail clippings, unlike blood samples, can be obtained noninvasively. They also take up little space and can be stored at room temperature for at least 1 month without affecting spectrometer outcomes.

“The proposed test may become particularly useful in low and middle income countries, where laboratories are often located long distances from where patients live,” said Prof. Delanghe.

Related Links:

American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.